171 related articles for article (PubMed ID: 37917577)
1. Risk and Prognostics of Second Primary Cancer After Prostate Radiation Therapy.
Liu EK; Daniels TB; Lischalk JW; Oh C; Haas JA; Evans AJ; Byun DJ
Urol Pract; 2024 Jan; 11(1):146-152. PubMed ID: 37917577
[TBL] [Abstract][Full Text] [Related]
2. Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.
Mohamad O; Tabuchi T; Nitta Y; Nomoto A; Sato A; Kasuya G; Makishima H; Choy H; Yamada S; Morishima T; Tsuji H; Miyashiro I; Kamada T
Lancet Oncol; 2019 May; 20(5):674-685. PubMed ID: 30885458
[TBL] [Abstract][Full Text] [Related]
3. Cancer incidence after localized therapy for prostate cancer.
Moon K; Stukenborg GJ; Keim J; Theodorescu D
Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
[TBL] [Abstract][Full Text] [Related]
4. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery.
Brenner DJ; Curtis RE; Hall EJ; Ron E
Cancer; 2000 Jan; 88(2):398-406. PubMed ID: 10640974
[TBL] [Abstract][Full Text] [Related]
5. Is there an increased risk of second primaries following prostate irradiation?
Movsas B; Hanlon AL; Pinover W; Hanks GE
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):251-5. PubMed ID: 9607337
[TBL] [Abstract][Full Text] [Related]
6. Comparing Risk for Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer, 2002-2015.
Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
[TBL] [Abstract][Full Text] [Related]
7. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
[TBL] [Abstract][Full Text] [Related]
8. Does muscle invasive bladder cancer following pelvic radiotherapy portend worse prognosis? A seer-based study.
Natale C; Leinwand G; Zeineddine F; Silberstein JL; Krane LS
Cancer Treat Res Commun; 2020; 24():100177. PubMed ID: 32454387
[TBL] [Abstract][Full Text] [Related]
9. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
10. Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data.
Abdel-Wahab M; Reis IM; Wu J; Duncan R
Urology; 2009 Oct; 74(4):866-71. PubMed ID: 19628258
[TBL] [Abstract][Full Text] [Related]
11. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.
Berrington de Gonzalez A; Wong J; Kleinerman R; Kim C; Morton L; Bekelman JE
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):295-302. PubMed ID: 25636756
[TBL] [Abstract][Full Text] [Related]
12. A Population-Based Study of Secondary Prostate Cancer Risk after Radiotherapy in Male Patients with Rectal Cancer: A Retrospective Cohort Study.
Chuang JP; Lee YC; Lee JC; Lu CL; Li CY
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 31013982
[No Abstract] [Full Text] [Related]
13. Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.
Joung JY; Lim J; Oh CM; Jung KW; Cho H; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
PLoS One; 2015; 10(10):e0140693. PubMed ID: 26469085
[TBL] [Abstract][Full Text] [Related]
14. Association of colorectal cancer and prostate cancer and impact of radiation therapy.
Huo D; Hetzel JT; Roy H; Rubin DT
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1979-85. PubMed ID: 19531678
[TBL] [Abstract][Full Text] [Related]
15. Estimating the risk of developing secondary hematologic malignancies in patients with T1/T2 prostate cancer undergoing diverse treatment modalities: A large population-based study.
Mo X; Zhou M; Yan H; Chen X; Wang Y
Cancer Med; 2021 Aug; 10(15):5338-5346. PubMed ID: 34189859
[TBL] [Abstract][Full Text] [Related]
16. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
17. Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis.
Wu Y; Li Y; Han C; Chong Y; Kang K; Liu Z; Zhang F
Future Oncol; 2022 Feb; 18(4):445-455. PubMed ID: 35018785
[TBL] [Abstract][Full Text] [Related]
18. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.
Abhyankar N; Hoskins KF; Abern MR; Calip GS
BMC Cancer; 2017 Sep; 17(1):659. PubMed ID: 28946846
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Second Primary Cancer Risk Among Men Receiving Primary Radiotherapy vs Surgery for the Treatment of Prostate Cancer.
Bagshaw HP; Arnow KD; Trickey AW; Leppert JT; Wren SM; Morris AM
JAMA Netw Open; 2022 Jul; 5(7):e2223025. PubMed ID: 35900763
[TBL] [Abstract][Full Text] [Related]
20. Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up.
Vuolukka K; Auvinen P; Palmgren JE; Aaltomaa S; Kataja V
BMC Cancer; 2020 May; 20(1):453. PubMed ID: 32434560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
